Added to YB: 2024-07-01
Pitch date: 2024-07-01
ROIV [bullish]
Roivant Sciences Ltd.
+104.06%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
Market Cap
$14.1B
Pitch Price
$10.83
Price Target
N/A
Dividend
N/A
EV/EBITDA
-9.39
P/E
-20.20
EV/Sales
505.07
Sector
Biotechnology
Category
value
Raging Bull Investments Stock Idea - Roivant Sciences Ltd.
ROIV: Biotech co undervalued vs balance sheet; free pipeline options. Aggressive buybacks ($648M at $9.10/sh, 9% of shares) + $850M authorized. Market ignoring value until crystallized. Returns of capital will eventually matter. Trades below cash value despite pipeline progress.
Read full article (1 min)